(S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetic acid, 97%, 1g

3,5-dibromo-1-[2-(1,3-dioxolan-2-yl)ethyl]-1H-1,2,4-triazole, 95.0%, 2g

3-Quinolinecarboxaldehyde>96.0%(GC)(T)1g

(1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl)boronic acid, 95.0%, 10g

1,5-Diaminonaphthalene (purified by sublimation)>99.5%(GC)1g

(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid, 97.0%, 250mg

boc-his(trt)-oh, 95.0%, 5g

5-(2-chlorophenyl)-4-ethyl-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

Chamomile oil, blue, 10 ml, glass packaging

(3aS,8aR)-2-(Pyridin-2-ylmethyl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole, 97%, 1g

2-Chloro-9-isopropyl-N-(4-methoxybenzyl)-9H-purin-6-amine, 95.0%, 5g

4,7-dimethoxy-2-piperazin-1-yl-1,3-benzothiazole, 95.0%, 1g

4-Fluoro-1-methyl-1H-pyrazole, 98%, 500mg